The assumption that intestinal metaplasia is a prerequisite for intraepithelial neoplasia/dysplasia and adenocarcinoma in the distal esophagus has been challenged by observations of adenocarcinoma without associated intestinal metaplasia. This study describes our experience of intestinal metaplasia in association with early Barrett neoplasia in distal esophagus and gastroesophageal junction. We reviewed the first endoscopic mucosal resection of 139 patients with biopsy-proven neoplasia. In index endoscopic mucosal resection, 110/139 (79%) cases showed intestinal metaplasia. Seven had intestinal metaplasia on prior biopsy specimens and three had intestinal metaplasia in subsequent specimens, totaling 120/139 (86%) patients showing intestinal metaplasia at some point supporting the theory of sampling error for absence of intestinal metaplasia in some cases. Those without intestinal metaplasia (13%) were enriched for higher stage disease (T1a Stolte m2 or above) supporting the assertion of obliteration of intestinal metaplasia by the advancing carcinoma. All cases of intraepithelial neoplasia and T1a Stolte m1 carcinomas had intestinal metaplasia (42/42). The average density of columnar-lined mucosa showing goblet cells was significantly less in shorter segments compared to those ≥ 3 cm (0.31 vs 0.51, P = 0.0304). Cases where segments measured less than 1 cm were seen in a higher proportion of females and also tended to lack intestinal metaplasia. We conclude that early Barrett neoplasia is always associated with intestinal metaplasia; absence of intestinal metaplasia is attributable to sampling error or obliteration of residual intestinal metaplasia by neoplasia and those with segments less than 1 cm show atypical features for Barrett-related disease (absent intestinal metaplasia and female gender), supporting that gastroesophageal junction adenocarcinomas are heterogeneous.
The assumption that intestinal metaplasia is a prerequisite for intraepithelial neoplasia/dysplasia and adenocarcinoma in the distal esophagus has been challenged by observations of adenocarcinoma without associated intestinal metaplasia. This study describes our experience of intestinal metaplasia in association with early Barrett neoplasia in distal esophagus and gastroesophageal junction. We reviewed the first endoscopic mucosal resection of 139 patients with biopsy-proven neoplasia. In index endoscopic mucosal resection, 110/139 (79%) cases showed intestinal metaplasia. Seven had intestinal metaplasia on prior biopsy specimens and three had intestinal metaplasia in subsequent specimens, totaling 120/139 (86%) patients showing intestinal metaplasia at some point supporting the theory of sampling error for absence of intestinal metaplasia in some cases. Those without intestinal metaplasia (13%) were enriched for higher stage disease (T1a Stolte m2 or above) supporting the assertion of obliteration of intestinal metaplasia by the advancing carcinoma. All cases of intraepithelial neoplasia and T1a Stolte m1 carcinomas had intestinal metaplasia (42/42). The average density of columnar-lined mucosa showing goblet cells was significantly less in shorter segments compared to those ≥ 3 cm (0.31 vs 0.51, P = 0.0304). Cases where segments measured less than 1 cm were seen in a higher proportion of females and also tended to lack intestinal metaplasia. We conclude that early Barrett neoplasia is always associated with intestinal metaplasia; absence of intestinal metaplasia is attributable to sampling error or obliteration of residual intestinal metaplasia by neoplasia and those with segments less than 1 cm show atypical features for Barrett-related disease (absent intestinal metaplasia and female gender), supporting that gastroesophageal junction adenocarcinomas are heterogeneous. Barrett esophagus is widely accepted to have a risk of progression to intraepithelial neoplasia and invasive adenocarcinoma. Most if not all published guidelines recommend commencing a program of surveillance with interval biopsies to detect early neoplasia. However, a globally accepted consensus for the diagnostic criteria of Barrett esophagus (and thus when to start and finish surveillance) has not been reached.
In the landmark paper of 1977, Paull et al 1 published on the morphological heterogeneity of Barrett mucosa herein referred to as columnar-lined mucosa. They observed heterogeneity of the mucosa signified by three metaplastic mucosal types, namely gastric fundic-type mucosa, junctional-type mucosa, and villiform mucosa with columnar epithelium and intestinal-type goblet cells. Goblet cells were seen in greater density more proximally, an observation that has since been validated by several others. 2, 3 The intestinalized epithelium or intestinal metaplasia, as it is also known, can be further characterized according to mucin histochemical and immunohistochemical expression, 4 however these are not usually required for routine diagnosis, as the hematoxylin and eosin appearance of goblet cells is sufficient. Intestinal metaplasia is the only metaplastic change that has an established association with progression to esophageal adenocarcinoma. [5] [6] [7] For this reason, some guidelines reserve the diagnosis of Barrett esophagus and endoscopic surveillance for only those lesions where intestinal metaplasia is histologically demonstrated. 8, 9 Other guidelines, such as those of the British Society of Gastroenterology, 10 would recommend surveillance on columnar-lined mucosa segments 43 cm in absence of histologic identification of intestinal metaplasia. They acknowledge the heterogeneity that is present in this mucosa and assume that an absence of intestinal metaplasia on biopsy is a sampling error. They also recommend surveillance on shorter segment columnar-lined mucosa conditional on the histologic identification of intestinal metaplasia. Australian Guidelines recommend that columnar-lined mucosa segments without intestinal metaplasia should have a repeat at 3-5 years and discharge from surveillance if still without intestinal metaplasia. 11 Recently, there have been two conceptual challenges to the assumption that intestinal metaplasia is a fundamental intermediary of intraepithelial neoplasia and malignancy.
The first challenge is based on the work of Schmidt et al 12 who proposed an alternative pathway of intraepithelial neoplasia. Brown et al 13 built on this work, describing morphological and immunohistochemical features of the so called 'nonadenomatous' type, which is considered analogous to the foveolar type of gastric dysplasia. Brown et al also found a statistically significant association with the presence of non-adenomatous dysplasia and the absence of intestinal metaplasia in esophagectomy specimens and thus surmised that this observation might indicate the existence of an alternative pathway of carcinogenesis, independent of intestinal metaplasia.
A second challenge is from a Japanese and German collaborative group 14, 15 who observe in endoscopic mucosal resection specimens that early stage and/or small adenocarcinoma were frequently adjacent to non-intestinalized columnar-lined mucosa only. They reason that early lesions are less likely to obliterate the mucosa from which they derive (a criticism of previous works) and propose that the frequent abutment of neoplasia with nonintestinalized mucosa is evidence of a pathway of carcinogenesis directly from the non-intestinalized metaplasia, independent of intestinal metaplasia.
Smith et al 16 recently rebutted the assertion that early adenocarcinoma arises from non-intestinalized epithelium with support of their own findings from examining the specimens from 21 patients who had early adenocarcinoma on endoscopic mucosal resection. They found that despite intestinal metaplasia being absent in 37% of endoscopic mucosal resection specimens, all but one patient demonstrated evidence of intestinal metaplasia in a prior or subsequent specimen. In this paper, the authors specify that the intestinal metaplasia be defined by non-dysplastic columnar-lined epithelium that contains goblet cells, because of the theoretical possibility of new goblet cell phenotype expression in neoplastic tissue, independent of the surrounding non-neoplastic mucosa. They note that all patients had goblet cells identified in an endoscopic mucosal resection specimen if dysplastic mucosa is taken into consideration.
In our own experience, goblet cells are often identified in association with early neoplasia of the distal esophagus or gastroesophageal junction. This study was undertaken to confirm our impression that early neoplasia of the distal esophagus or gastroesophageal junction is virtually always associated with intestinal metaplasia in endoscopic mucosal resection specimens.
Materials and methods
The endoscopic mucosal resection specimens included in the study were those resected following a diagnosis of unequivocal glandular intraepithelial neoplasia or adenocarcinoma in biopsies of the distal esophagus or gastroesophageal junction from patients who attended Sir Charles Gairdner Hospital, Western Australia, between 2006 and 2014. If multiple procedures were performed over time, only the first episode endoscopic mucosal resection specimen was included as the index specimen from each patient. Pathological features were tabulated for each case, including lesion type, stage, and Stolte classification. The Stolte system classifies the infiltration of early carcinomas (T1) as follows: 17, 18 T1a m1. Carcinoma limited to the lamina propria of the Barrett mucosa. sm3. Infiltration into the lower third of the submucosa of the esophageal mucosa.
If intestinal metaplasia was absent on the index endoscopic mucosal resection specimen, previous and subsequent biopsies, endoscopic mucosal resections, and formal resections for that patient were examined to establish the historical presence or absence of intestinal metaplasia in each case. Endoscopic mucosal resection specimens that were diagnosed as stage T1 adenocarcinoma from Envoi Specialist Pathologists Laboratory (Queensland) were also reviewed to enrich the series with early stage adenocarcinoma.
Preparation and Examination of Endoscopic Mucosal Resection Specimens
Specimens obtained from endoscopic mucosal resection included tissue taken as a single piece or multiple pieces. All were fixed and serially sliced at 2-3 mm intervals and processed in entirety, using a standard protocol as previously described. 18 
Mucosal Assessment
One or more of four investigators (BA, JB, IB, and MPK) performed morphological assessment of intestinal metaplasia by examining all slides from each tissue block of the entire endoscopic mucosal resection. Intestinal metaplasia was considered to be present when goblet cells were present in nondysplastic columnar mucosa. Goblet cells were identified morphologically on hematoxylin and eosin stained slides as cells with a distended lightly hematoxylin stained vacuole and compressed basal nucleus with displacement of the membranes of adjacent cells (See Figures 1 and 2 ). All the lesions were confirmed to be either in the tubular esophagus or at the gastroesophageal junction (as defined by proximal extent of gastric folds) by the interventional endoscopist. Maximal segment length as measured on endoscopy was stratified by cases o1 cm and ≥ 1 cm in line with the recommendations of Shaheen et al. 9 
Semi-Quantitative Assessment
One or more of three investigators (BA, JB, and MPK) performed a semi-quantitative assessment of intestinal metaplasia on a subset of cases by examining representative slides from each tissue block of the entire endoscopic mucosal resection. Goblet cells were identified morphologically as described previously. The goblet cell presence was quantified by subdividing the columnar-lined mucosa into approximate 1 mm linear units as defined by one field of view of the Olympus DX40 microscope using a × 20 objective and eyepieces of field number 22 (calculated field of view diameter: 1.1 mm). Fields comprising columnarlined mucosa with and without goblet cells were tallied at one level of each tissue block and calculated as a proportion of the total counted. Sub-squamous glands showing goblet cells were not tallied. Wellorganized, native oxyntic-type mucosa likely to represent gastric fundus was not included in the assessment to ensure only columnar-lined mucosa of the esophagus was assessed. Areas where the type of surface epithelium was not identifiable due to orientation, denudation, or ulceration were not included.
Statistical Analysis
Means were compared using independent sample ttests except for the semi-quantitative analysis where the Wilcoxon-Mann-Whitney test was used. Proportions were compared using the Fisher exact test. All analysis was performed using SAS 9.4. 
Results

Demographics
There were 139 patients overall, including 122 males and 17 females. The age range was 33-88 years old. The case distributions by highest stage lesion present at index endoscopic mucosal resection were 20 intraepithelial neoplasia only, 89 T1a and 30 T1b. The stratification of T1a cases by Stolte staging was 24 of m1, 41 of m2, 15 of m3, and 9 of m4. Table 1 also shows the endoscopic data that were available for 124/139 cases.
Characteristics of Cases with and without Intestinal Metaplasia on Index Endoscopic Mucosal Resection Specimen
One hundred and ten of 139 (79%) cases showed intestinal metaplasia on index endoscopic mucosal resection (Table 1) . Exploring the procedural history of patients that did not show intestinal metaplasia, seven had documented intestinal metaplasia on prior biopsy specimens and three had intestinal metaplasia in subsequent specimens, thus totaling 120/139 (86%) patients showing intestinal metaplasia at some point if not the index endoscopic mucosal resection.
One hundred and twenty of 139 cases of early neoplasia defined by intraepithelial neoplasia (n = 20) and T1 carcinomas (n = 100) showed intestinal metaplasia. The 19 cases with no intestinal metaplasia were all T1 carcinomas, whereas all cases with intraepithelial neoplasia only showed goblet cells. Intestinal metaplasia was present in 95% (42/44) of index endoscopic mucosal resection for intraepithelial neoplasia and earliest stage carcinomas (T1a Stolte m1) considered together. Both cases that did not show intestinal metaplasia in the index endoscopic mucosal resection had shown intestinal metaplasia on a prior biopsy; therefore, 100% of intraepithelial neoplasia and early carcinomas up to Stole stage M1 were associated with intestinal metaplasia.
Cases that lacked intestinal metaplasia on index endoscopic mucosal resection were not only associated with a higher proportion of short segment columnar-lined mucosa (as defined as o 1 cm) and also with more advanced stage (American Joint Committee on cancer tumor stage T1b). Table 2 details the characteristics of the 19 cases that had no documented intestinal metaplasia on index endoscopic mucosal resection or historically. Seven of the 19 cases had subsequent formal resections with no intestinal metaplasia. Notwithstanding, patients lost to follow-up or cured by intervening procedures could represent some of the other cases.
Examining the features of these 19 cases (in two endoscopic data were not available), there was an enrichment of cases with short segment columnarlined mucosa (as defined as o 1 cm). Notably, there were only two cases with a columnar-lined mucosa segment 41 cm and only one of these with a segment 43 cm. The stage of disease in these cases were T1b and T1a Stolte m3.
Comparison of Cases by Endoscopic Measurement of Columnar-Lined Mucosa Segment
Endoscopic data were available in 124 cases. Nineteen of 124 (15%) lesions were at the gastroesophageal junction with a segment o 1 cm in length or no columnar-lined mucosa segment identified on endoscopy. The group of cases with segments o1 cm had a significantly higher proportion of female patients (P = 0.0004). Eight of 16 (50%) female cases had segment lengths o1 cm compared to 11/97 (10%) of male cases. Intestinal metaplasia was present in a significantly higher proportion among cases with segments ≥ 1 cm (Po0.0001) at 78%, compared to only 37% of cases with segments o1 cm. No significant difference in mean age was observed. Table 3 details the semi-quantitative analysis findings, where there was significantly less field units of columnar-lined mucosa available for examination in columnar-lined mucosa segments o3 cm (30.4 vs 109.0, P = 0.0012), but also the proportion of goblet cell bearing field units were lower in the segments o3 cm (0.31 vs 0.51, P = 0.0304), indicating a higher density of goblet cells in segments ≥ 3 cm.
Comparison of Cases by Stage
There were a significantly higher proportion of cases with intestinal metaplasia on index endoscopic mucosal resection at the earliest stages (intraepithelial neoplasia only and Stolte m1, see Table 4 , P-value = 0.0007). Cases with short segments were not significantly under represented (see Table 4 , P-value = 0.07).
There was no significant difference in gender or mean age when cases were analyzed by stage.
Discussion
The primary aim of this study was to confirm that Barrett esophagus-related neoplasia is associated with intestinal metaplasia by analyzing dysplasia and early adenocarcinomas in a large cohort of endoscopic mucosal resections. Secondarily, we aimed to analyze any factors that could contribute to the absence of intestinal metaplasia in terms of a pathway of carcinogenesis independent of intestinal metaplasia or other factors such as sampling error. We demonstrated that 120/139 cases showed intestinal metaplasia. The 19 cases with no intestinal metaplasia were all invasive carcinomas, whereas all with intraepithelial neoplasia only showed intestinal metaplasia. Cases that lacked intestinal metaplasia on index endoscopic mucosal resection were associated with a significantly higher proportion of short segment columnar-lined mucosa (o 1 cm) and also with higher stage disease. We are of the opinion that higher stage lesions may obliterate the underlying non-neoplastic mucosa from which they developed. Our finding supports this view that all of the lowest stage cases (Stolte m1 or less) are associated with intestinal metaplasia. In contrast, the two cases with absent intestinal metaplasia that had columnar-lined mucosa 1 cm or longer had higher stage disease (see Table 2 ; T1b and T1a Stolte m3, respectively). With these assertions, it appears that all long segment Barrett-related neoplasia are likely to show intestinal metaplasia. We conclude that all Barrett-related neoplastic lesions in segments 1 cm or longer are associated with intestinal metaplasia based on the finding of intestinal metaplasia in 100% of intraepithelial neoplasia and Stolte m1 carcinomas.
When we further examined the characteristics of cases that showed segments o 1 cm, we found higher proportions of cases that (1) lacked intestinal metaplasia and (2) female gender, which are both unusual trends compared to established trends of adenocarcinoma of the distal esophagus associated with Barrett disease. 19, 20 The possibility that these cases represent a different etiology or are cardiabased tumors growing into the gastroesophageal junction is a potential explanation. An in-depth study including a large series of these tumors is warranted.
Observations that intestinal metaplasia is detected later in the course of endoscopic surveillance in short segment columnar-lined mucosa compared to long is worth discussion. 21 It could be that goblet cells become more dense the further the segment extends from the gastroesophageal junction, as it is well documented that goblet cells are most richly distributed in the proximal portions of a columnarlined mucosa segment. [1] [2] [3] We found the proportion of linear field units that contained goblet cells per case was significantly lower in columnar-lined mucosa o 3 cm. Sampling bias for the detection of goblet cells in this group is mitigated by the fact that often times smaller segments are more completely sampled by an endoscopic mucosal resection procedure. This finding further supports a difference in distribution relative to either segment length or maximum distance from the gastroesophageal junction. Cotton et al 22 have observed that dysplasia is also preferentially present in the proximal half of segments. There are a number of studies that find Barrett's related dysplasia and early adenocarcinoma are more prevalent in the right hemisphere of the esophagus on a circumferential axis, [23] [24] [25] but no studies describing the circumferential distribution of goblet cells have been identified.
Like Smith et al, 16 we conclude that intestinal metaplasia accompanies virtually all glandular neoplasia arising in long segments of columnarlined mucosa, excepting where the lesion may have obliterated the residual non-neoplastic mucosa. The scope of this study does not address the suitability of biopsy protocols to detect intestinal metaplasia in Barrett mucosa, or the minimum endoscopically measured length of segment that should be considered as Barrett mucosa. However, where we have observed neoplasia of the gastroesophageal junction in short segment or absent columnar-lined mucosa (cases falling short of accepted endoscopic criteria for Barrett esophagus), we report features that are not typical of Barrett-related neoplasia; including lack of intestinal metaplasia and a higher likelihood to be female; suggesting that some of these lesions may have a different origin or develop along a different pathway. 
